Princeton, NJ, United States of America

Brent Chandler



 

Average Co-Inventor Count = 12.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • New Haven, CT (US) (2007 - 2012)
  • Princeton, NJ (US) (2012 - 2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Brent Chandler: Innovator in Pharmaceutical Compounds

Introduction

Brent Chandler is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating hyper-proliferative disorders. With a total of 7 patents to his name, Chandler's work has the potential to impact many lives.

Latest Patents

Chandler's latest patents include innovative compounds such as substituted 4-amino-pyrrolotriazine derivatives. These compounds are useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. His inventions relate to novel pyrrolotriazine compounds, pharmaceutical compositions containing such compounds, and their use for the prevention and/or treatment of these medical conditions.

Career Highlights

Throughout his career, Brent Chandler has worked with prominent companies in the pharmaceutical industry, including Bayer Healthcare LLC and Bayer Pharmaceuticals Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Chandler has collaborated with notable colleagues such as Julie A. Dixon and Barton W. Phillips. These partnerships have fostered an environment of innovation and creativity in his work.

Conclusion

Brent Chandler's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…